Reported Side Effects (Mild and Rare) Nausea Occasionally reported when injected near the stomach or when dosing is too high Headache Often from stacking with other peptides (e.g., GH secretagogues) Dizziness or lightheadedness Linked to vasodilation or nitric oxide regulation Injection site irritation Mild redness or swelling is possible with subcutaneous use These effects are usually short-lived and self-resolving , especially when using proper injection technique and sterile reconstitution practices
Users who tolerate 0.5% for two weeks and immediately jump to 2% often encounter problems
However, titrating with niclosamide reduces the ATP content as readily measured using assays for cell viability, such as Cell Titer Glo (30)
Because many peptides are not FDA-approved, the full long-term safety profile is not established, which is why medical supervision and dose individualization are important
Nitric oxide system modulation and angiogenesis
Peptide Information Cagrilintide Peptide Structure Source: PubChem Lyophilized Peptides: Our cagrilintide is provided as a lyophilized (freeze-dried) powder